← Back to Clinical Trials
Recruiting NCT05671406

NCT05671406 RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05671406
Status Recruiting
Phase
Sponsor University of Texas at Austin
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 220 participants
Start Date 2024-06-27
Primary Completion 2027-03-31

Trial Parameters

Condition Hypertension
Sponsor University of Texas at Austin
Study Type INTERVENTIONAL
Phase N/A
Enrollment 220
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-06-27
Completion 2027-03-31
Interventions
Sensor-controlled digital gameSensor only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of physical activity in Native American adults with hypertension (HTN). Half of the participants will receive the SCDG app and physical activity sensors and the other half will receive only the physical activity sensors. Native American participants with hypertension (HTN) in the sensor controlled digital game intervention group will show increased PA behaviors; improved HTN knowledge, self-care behaviors, self-efficacy, motivation, and quality of life (QoL); and larger reduction in systolic and diastolic blood pressure and cardiac hospitalizations at baseline,3 months, and 6 months as compared to participants in the sensor-only control group.

Eligibility Criteria

Inclusion Criteria: * Adults in a Native American tribal community in southeastern U.S. * Age 18 years or older * Systolic BP ≥140mm Hg and/or diastolic BP ≥90mm Hg on 2 separate measurements or who are on antihypertensive medication will be included. * Pass a mini-cognitive screen * Able to independently walk without using a walker or requiring human assistance (ambulation/locomotion item on the Outcome and Assessment Information). Exclusion Criteria: * Severe visual (e.g., legal blindness) or tactile (e.g., severe arthritis) impairments that adversely prevent use of a smart phone or sensor devices; * Chronic kidney disease stage 4-5, * Diagnosis of end stage or terminal illness (e.g., cancer or heart failure) * Prior heart transplantation or implantation of a durable mechanical circulatory support device (e.g., left ventricular assist devise) due to unique self-care needs.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology